POWERFUL PRODUCTS
MEET POWERFUL SAVINGS1,2

POWERFUL PRODUCTS
MEET POWERFUL SAVINGS1,2

Actor Portrayal
Answer one simple question to find the right savings program for you

Savings & Financial
Support
Find your savings program

Powerful hypertension treatment1,2 can be within reach—and within budget. Reduce the out-of-pocket costs of EDARBI® (azilsartan medoxomil) and EDARBYCLOR® (azilsartan medoxomil/chlorthalidone) through one of our savings programs.

If eligible, you can access savings regardless of insurance coverage. There are options for you whether you are insured, noninsured, or cash-paying.

$15/month*

Insured Patients*

$40/month*†

Cash-Paying Patients†
*

Eligibility requirements for patients utilizing insurance: This offer cannot be used if a patient is a beneficiary of, or any part of their prescription is covered by: (1) any federal or state healthcare program (Medicare, Medicaid, TriCARE, etc.), including a state pharmaceutical assistance program; (2) the Medicare Prescription Drug Program (Part D), or if the patient is currently in the coverage gap; or (3) has insurance that is paying the entire cost of the prescription. Offer is void where prohibited by law.

Any patient may opt to take advantage of Azurity’s cash-payment programs; patients must attest the claim is not being billed through insurance. Prescriptions for cash-paying patients will be triaged to Azurity Patient Direct, which is fulfilled by Truax Patient Services. You will receive a call from Truax Patient Services or you may call (844) 289-3981 to inquire about your prescription.

Azurity Solutions E-Z RxTM
Low costs for commercially insured patients

If you’re commercially insured, the Azurity Solutions E-Z Rx enables you to pay just $15 for 30 days of EDARBI or EDARBYCLOR through participating pharmacies.

Get connected to one of the E-Z Rx pharmacies near you through our pharmacy locator.

Find aN E-Z Rx pharmacy

Any patient may opt to take advantage of Azurity’s Instant Savings Card, regardless of commercial insurance coverage.

Patients enrolled in state/federal programs (Medicare, Medicaid, VA/DOD, etc.) are not eligible for copay discount savings through Azurity Solutions E-Z Rx or any Azurity Instant Savings Card.

Arbor Patient Direct*
* Arbor Pharmaceuticals, LLC is a subsidiary of Azurity Pharmaceuticals, Inc.
A guaranteed price for everyone

Arbor Patient Direct* is a free program whether you have insurance or not. With Arbor Patient Direct*, you pay a guaranteed price for EDARBI and EDARBYCLOR.

  • Cash-only savings
  • Home delivery
  • All patients eligible
  • No insurance required
Enroll now

Copay Savings Card
Save at a pharmacy of your choice

If you’re a commercially insured patient, use our Copay Savings Card and pay as little as $15* for EDARBI or EDARBYCLOR prescriptions. Use these instant savings at any pharmacy of your choice.

WELCOME TO THE EDARBI® (AZILSARTAN MEDOXOMIL) AND EDARBYCLOR® (AZILSARTAN MEDOXOMIL/CHLORTHALIDONE) COPAY SAVINGS CARD PROGRAM

FOR PATIENTS: If your copay for EDARBI or EDARBYCLOR exceeds $15 (insured patients) present this card to the pharmacist for an instant rebate.* Benefit limitations apply. Patient is responsible for the remaining balance after benefit limits are reached. For questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call (877) 264-2440 (8:00 a.m.-8:00 p.m. ET, Monday-Friday).

FOR PHARMACISTS: Benefit limitations apply.* Additional program details are available at www.edarbi.com. When you use this card, you are certifying that you have not submitted and will not submit a claim for reimbursement under any federal, state, or other governmental programs for this prescription. By redeeming this coupon, you agree that you understand and will abide by the terms and conditions of this offer, posted at www.mckesson.com/mprstnc.

Request Copay Savings Card

Please provide the following information to request a Copay Savings Card.

*Fields are required.

Information provided on this form shall be treated in accordance with our Privacy Policy, as currently in effect.

WELCOME TO THE SAVINGS PROGRAM!

Your savings card should download in a few seconds. If not, click here to download your savings card.
*Must meet eligibility requirements. Azurity Pharmaceuticals, Inc. reserves the right to rescind, revoke, amend or terminate this offer without notice at any time.
See Terms and Conditions

EDARBI and EDARBYCLOR Copay Savings Program Terms and Conditions

To the Patient: If your copay for EDARBI or EDARBYCLOR exceeds $15 (insured patients), present this card to the pharmacist for an instant rebate. Benefit limitations apply. Patient is responsible for the remaining balance after benefit limits are reached. For questions regarding your eligibility or benefits or if you wish to discontinue your participation, call (877) 264-2440 (8:00 a.m.-8:00 p.m. ET, Monday-Friday).

To the Pharmacist: Benefit limitations apply. Additional program details are available at www.edarbi.com. When you use this card, you are certifying that you have not submitted and will not submit a claim for reimbursement under any federal, state, or other governmental programs for this prescription. By redeeming this coupon, you agree that you understand and will abide by the terms and conditions of this offer, posted at www.mckesson.com/mprstnc.

For questions regarding setup, claim transmission, patient eligibility, or other issues, call (877) 264-2440 (8:00 a.m.-8:00 p.m. ET, Monday-Friday). 

*Must meet eligibility requirements. Azurity Pharmaceuticals, Inc. reserves the right to rescind, revoke, amend or terminate this offer without notice at any time.

1. White WB, Weber MA, Sica D, et al. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension. 2011;57(3):413-420. doi:10.1161/HYPERTENSIONAHA.110.163402
2. Cushman WC, Bakris GL, White WB, et al. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. Hypertension. 2012;60(2):310-318.